Loading organizations...
Loading organizations...
Key people at Sino Biopharmaceutical.
Sino Biopharmaceutical was founded by Ping Tse (Founder & Sr. Vice Chairman).
Key people at Sino Biopharmaceutical.
Sino Biopharmaceutical was founded by Ping Tse (Founder & Sr. Vice Chairman).
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 9, 2025 | Sanegene Bio | $110.0M Series B | — | Eli Lilly and Company, Invus, K2 Venture Partners, Lake Bleu Capital, Legend Capital, Northern Light Venture Capital, Oriza Holdings, Qiming Venture Partners, SymBiosis, Tencent, TF Capital, TruMed, Vivo Capital |
| Nov 25, 2025 | Phrontline Biopharma | $60.0M Pre-Series A | 王及 | Decheng Capital, Med-Fine Capital, Samsung |
| Aug 25, 2022 | HanchorBio | $20.0M Series A | Sino Biopharmaceutical | Zero2IPO |
| Aug 1, 2021 | XtalPi | $400.0M Series D | OrbiMed, RRJ | 5Y Capital, Koch Fund, Sequoia Capital China, Sequoia Capital |
| Nov 9, 2019 | Akeso | $150.0M Series D | Loyal Valley Capital, Sino Biopharmaceutical | AIHC Capital, CDG International, Lake Bleu Capital, OrbiMed, Shenzhen Capital Group |
| Aug 1, 2015 | LifeBond | $27.0M Series D | — | Pitango Venture Capital, Adams Street Partners |